You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

vortioxetine

Showing 51 - 75 of 110
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Depressive Disorder, Major, Inflammation Trial in Amsterdam (Celecoxib 400mg, Placebo)

Recruiting
  • Depressive Disorder, Major
  • Inflammation
  • Celecoxib 400mg
  • Placebo
  • Amsterdam, Netherlands
    Department of Psychiatry Amsterdam UMC
Sep 28, 2022

Depression Trial in Korea, Republic of (transcranial direct current stimulation (tDCS))

Recruiting
  • Depression
  • transcranial direct current stimulation (tDCS)
  • Chuncheon, Gangwon, Korea, Republic of
  • +4 more
Sep 13, 2022

Bipolar Disorder Depression Trial in Incheon, Seoul (Vortioxetine, Placebo)

Unknown status
  • Bipolar Disorder Depression
  • Vortioxetine
  • Placebo
  • Incheon, Korea, Republic of
  • +1 more
Aug 8, 2018

Healthy Volunteers Trial in United States (Vortioxetine, Paroxetine, Placebo)

Completed
Has Results
  • Healthy Volunteers
  • Vortioxetine
  • +2 more
  • Encino, California
  • +14 more
Aug 31, 2018

MDD Trial in Zaporizhzhia (Vortioxetine, Escitalopram)

Unknown status
  • Major Depressive Disorder
  • Zaporizhzhia, Ukraine
    State Institution "Zaporizhzhia Medical Academy of Postgraduate
Jan 8, 2019

Depressive Disorder, Major Trial in Estonia, Finland (Vortioxetine (IV), Placebo (IV), Vortioxetine (tablet))

Completed
  • Depressive Disorder, Major
  • Vortioxetine (IV)
  • +2 more
  • Tallinn, Estonia
  • +6 more
Jun 18, 2018

MDD Trial (Modafinil, Placebo)

Withdrawn
  • Major Depressive Disorder
  • (no location specified)
Mar 18, 2020

ADHD Trial in United States (vortioxetine 10 mg tablet, vortioxetine 20 mg tablet, Placebo tablet)

Completed
Has Results
  • Attention Deficit Hyperactivity Disorder
  • vortioxetine 10 mg tablet
  • +2 more
  • Beverly Hills, California
  • +14 more
Feb 5, 2018

MDD Trial in Canada (vortioxetine)

Completed
  • Major Depressive Disorder
  • vortioxetine
  • Edmonton, Alberta, Canada
  • +25 more
Jan 26, 2018

Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)

Completed
Has Results
  • Depressive Disorder, Major
  • Phoenix, Arizona
  • +49 more
Jul 20, 2022

Depression, Menopause, Vasomotor Disturbance Trial in Boston (vortioxetine)

Completed
Has Results
  • Depression
  • +4 more
  • vortioxetine
  • Boston, Massachusetts
    Massachusetts General Hospital
Jun 26, 2017

MDD Trial in Worldwide (Vortioxetine 10-20 mg, Placebo, SSRI)

Completed
  • Major Depressive Disorder
  • Vortioxetine 10-20 mg
  • +2 more
  • Tallinn, Estonia
  • +16 more
May 23, 2017

Depressive Disorder, Anxiety Disorder Trial in Germany, United States (Vortioxetine)

Completed
Has Results
  • Depressive Disorder
  • Anxiety Disorder
  • Vortioxetine
  • Washington, District of Columbia
  • +6 more
Feb 8, 2017

Switching From SSRI to Desvenlafaxine on Cognitive Functioning

Unknown status
  • Major Depressive Disorder
  • Sabadell, Spain
    Corporació Sanitària Parc Taulí
Apr 17, 2019

MDD Trial in Worldwide (Vortioxetine 10 mg, Paroxetine 20 mg, Placebo)

Completed
  • Major Depressive Disorder
  • Vortioxetine 10 mg
  • +2 more
  • Tallinn, Estonia
  • +17 more
Feb 27, 2017

MDD Trial in Worldwide (Vortioxetine 10-20 mg, Escitalopram 10-20 mg)

Completed
  • Major Depressive Disorder
  • Vortioxetine 10-20 mg
  • Escitalopram 10-20 mg
  • Helsinki, Finland
  • +15 more
Feb 27, 2017

Genecept Assay and Adverse Effects of Antidepressants

Completed
  • Depression
  • Adverse Effects
  • Genocept Assay
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Mar 14, 2018

MDD, Cognitive Impairment Trial in Toronto (Modafinil, Placebo)

Terminated
  • Major Depressive Disorder
  • Cognitive Impairment
  • Toronto, Ontario, Canada
    St. Michael's Hospital
Aug 6, 2019

Unipolar Major Depression, Stage I, II or III Breast Cancer Trial (Vortioxetine)

Withdrawn
  • Unipolar Major Depression
  • Stage I, II or III Breast Cancer
  • Vortioxetine
  • (no location specified)
Sep 29, 2016

TBI, Major Depression Trial (Vortioxetine, Placebo)

Withdrawn
  • TBI
  • Major Depression
  • Vortioxetine
  • Placebo
  • (no location specified)
Sep 1, 2016

MDD, Coronary Artery Disease Trial in Philadelphia (Vortioxetine)

Withdrawn
  • Major Depressive Disorder
  • Coronary Artery Disease
  • Vortioxetine
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 24, 2016

Social Anxiety Disorder, MDD Trial in New York (Vortioxetine, Placebo)

Unknown status
  • Social Anxiety Disorder
  • Major Depressive Disorder
  • Vortioxetine
  • Placebo
  • New York, New York
    The Medical Research Network, LLC
Aug 23, 2016

Panic Disorder Trial in Santa Rosa (Vortioxetine)

Completed
  • Panic Disorder
  • Vortioxetine
  • Santa Rosa, California
    Siyan Clinical Corporation
Jul 22, 2016

Severe Hepatic Impairment Trial in Miami (Vortioxetine)

Completed
Has Results
  • Severe Hepatic Impairment
  • Vortioxetine
  • Miami, Florida
    University of Miami
Dec 1, 2015

Healthy Men Trial in Rennes (Vortioxetine 10 mg, Vortioxetine 20 mg, Escitalopram 15 mg)

Completed
  • Healthy Men
  • Vortioxetine 10 mg
  • +3 more
  • Rennes, France
    FR801
Aug 31, 2015